Coronavirus
Coronavirus: China approves early-stage human trials for two vaccines
China has approved early-stage human tests for two experimental vaccines to combat the new coronavirus that killed over 100,000 people worldwide, state media Xinhua reported on Tuesday.
The vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech, and by the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group.
In March, China have the green-light for another clinical trial for a coronavirus vaccine candidate developed by military-backed China’s Academy of Military Medical Sciences and HK-listed biotech firm CanSino Bio, shortly after U.S. drug developer Moderna said it had begun human tests for their vaccine with the U.S. National Institutes of Health.
The World Health Organization said Monday that a safe and effective vaccine would be needed to fully halt the spread of COVID-19, which has killed more than 114,000 people worldwide.
“Our global connectedness means the risk of re-introduction and resurgence of COVID19 will continue,” WHO Director-General Tedros Adhanom Ghebreyesus told a virtual briefing from Geneva, stressing that “ultimately, the development and delivery of a safe and effective vaccine will be needed to fully interrupt transmission.”
-
News23 hours ago
Tinubu honours slain Delta soldiers with MON, OFR awards
-
Entertainment23 hours ago
Best-dressed female: I could have made similar mistake, says Femi Branch
-
Entertainment21 hours ago
Osita Iheme ‘Paw Paw’ reacts to his famous memes
-
News9 hours ago
[ICYMI] NNPC denies fuel price adjustment
-
Metro7 hours ago
Police neutralise two notorious bandits in Benue
-
News8 hours ago
X users to get free premium, premium+ subscriptions – Elon Musk
-
News7 hours ago
Two bodies recovered from submerged truck in US bridge collapse
-
Entertainment6 hours ago
Actress Eniola Ajao apologizes over Bobrisky’s best-dressed female saga